Company		Revenue (₹ Cr)			Profit (₹ Cr)		Per share		8Q profit
Symbol	Sector	Reported	YoY	QoQ	Reported	YoY	EPS	vs consensus	Trend
SUNPHARMA Sun Pharmaceutical Industries Ltd	Healthcare	14,478	up+8.9%	up+4.5%	3,125	up+2.9%	13.00	Beat +2.4% est. 12.70
DRREDDY Dr Reddys Laboratories Ltd	Healthcare	8,828	up+9.8%	up+3.0%	1,337	down-0.4%	16.14	Miss -6.6% est. 17.33
AUROPHARMA Aurobindo Pharma Ltd	Healthcare	8,286	up+6.3%	up+5.3%	848	up+3.8%	14.61	Miss -4.7% est. 15.33
CIPLA Cipla Ltd	Healthcare	7,589	up+7.6%	up+9.1%	1,353	up+3.7%	16.73	Beat +4.1% est. 16.08
LUPIN Lupin Ltd	Healthcare	7,048	up+24.2%	up+12.4%	1,485	up+72.9%	32.36	Beat +30.3% est. 24.83
ZYDUSLIFE Zydus Lifesciences Ltd	Healthcare	6,123	up+16.9%	down-6.9%	1,239	up+34.7%	12.51	Miss -4.2% est. 13.06
GLENMARK Glenmark Pharmaceuticals Ltd	Healthcare	6,047	up+76.1%	up+85.3%	610	up+72.3%	21.63	No estimate
BIOCON Biocon Ltd	Healthcare	4,296	up+19.7%	up+9.0%	133	up+392.6%	0.63	Beat +21.1% est. 0.55
ALKEM Alkem Laboratories Ltd	Healthcare	4,001	up+17.2%	up+18.7%	779	up+11.0%	63.99	No estimate
MANKIND Mankind Pharma Ltd	Healthcare	3,697	up+20.8%	up+3.6%	520	down-21.1%	12.39	Miss -9.6% est. 13.70
TORNTPHARM Torrent Pharmaceuticals Ltd	Healthcare	3,302	up+14.3%	up+3.9%	591	up+30.5%	17.46	Miss -3.8% est. 18.23
DIVISLAB Divis Laboratories Ltd	Healthcare	2,715	up+16.1%	up+12.7%	689	up+35.1%	25.95	Beat +6.4% est. 24.41
IPCALAB Ipca Laboratories Ltd	Healthcare	2,556	up+8.5%	up+10.7%	281	up+14.2%	11.14	No estimate
EMCURE Emcure Pharmaceuticals Ltd	Healthcare	2,270	up+13.4%	up+8.0%	251	up+24.3%	12.84	No estimate
PPLPHARMA Piramal Pharma Ltd	Healthcare	2,044	down-8.8%	up+5.7%	-99	down-530.4%	-0.75	Miss -120.6% est. -0.34
JUBLPHARMA Jubilant Pharmova Ltd	Healthcare	1,966	up+12.2%	up+3.4%	120	up+17.6%	7.55	No estimate
APLLTD Alembic Pharmaceuticals Ltd	Healthcare	1,910	up+15.9%	up+11.6%	184	up+20.3%	9.40	Beat +3.7% est. 9.07
ABBOTINDIA Abbott India Ltd	Healthcare	1,757	up+7.6%	up+1.1%	415	up+15.6%	195.43	No estimate
LAURUSLABS Laurus Labs Ltd	Healthcare	1,653	up+35.0%	up+5.3%	194	up+870.0%	3.61	Beat +45.3% est. 2.49
GLAND Gland Pharma Ltd	Healthcare	1,487	up+5.8%	down-1.3%	184	up+12.2%	11.15	Miss -18.2% est. 13.62
NATCOPHARM Natco Pharma Ltd	Healthcare	1,363	down-0.6%	up+2.6%	518	down-23.4%	28.94	No estimate
AJANTPHARM Ajanta Pharma Ltd	Healthcare	1,354	up+14.1%	up+3.9%	260	up+20.4%	20.83	No estimate
GRANULES Granules India Ltd	Healthcare	1,297	up+34.1%	up+7.2%	131	up+35.1%	5.38	No estimate
STAR Strides Pharma Science Ltd	Healthcare	1,221	up+4.6%	up+9.0%	132	up+83.3%	13.84	No estimate
JBCHEPHARM J B Chemicals & Pharmaceuticals Ltd	Healthcare	1,085	up+8.4%	down-0.8%	208	up+18.9%	13.27	No estimate
AKUMS Akums Drugs & Pharmaceuticals Ltd	Healthcare	1,018	down-1.5%	down-0.6%	43	down-35.8%	2.59	No estimate
GLAXO Glaxosmithkline Pharmaceuticals Ltd	Healthcare	980	down-3.1%	up+21.7%	257	up+2.0%	15.20	No estimate
SYNGENE Syngene International Ltd	Healthcare	911	up+2.2%	up+4.1%	67	down-36.8%	1.67	Miss -20.5% est. 2.10
VIYASH Viyash Scientific Ltd	Healthcare	850	up+130.4%	up+7.3%	73	up+1,116.7%	2.18	No estimate
INDGN Indegene Ltd	Healthcare	804	up+17.0%	up+5.7%	102	up+10.9%	4.25	No estimate
ERIS ERIS Lifesciences Ltd	Healthcare	792	up+6.9%	up+2.5%	134	up+39.6%	8.82	No estimate
WOCKPHARMA Wockhardt Ltd	Healthcare	782	down-3.3%	up+6.0%	82	n/a	4.80	No estimate
MARKSANS Marksans Pharma Ltd	Healthcare	720	up+12.1%	up+16.1%	99	up+1.0%	2.17	No estimate
AARTIDRUGS Aarti Drugs Ltd	Healthcare	653	up+9.2%	up+10.5%	45	up+28.6%	4.96	No estimate
DCAL Dishman Carbogen Amcis Ltd	Healthcare	653	down-17.2%	down-7.8%	65	up+97.0%	4.16	No estimate
PFIZER Pfizer Ltd	Healthcare	642	up+9.0%	up+6.5%	189	up+19.6%	41.32	No estimate
ALIVUS Alivus Life Sciences Ltd	Healthcare	588	up+16.0%	down-2.3%	130	up+36.8%	10.60	No estimate
UNICHEMLAB Unichem Laboratories Ltd	Healthcare	579	up+14.2%	up+9.9%	-12	down-148.0%	-1.69	No estimate
IOLCP IOL Chemicals & Pharmaceuticals Ltd	Healthcare	568	up+8.0%	up+2.9%	30	up+57.9%	1.02	No estimate
ASTRAZEN Astrazeneca Pharma India Ltd	Healthcare	559	up+37.0%	up+6.3%	54	up+42.1%	21.69	No estimate
COHANCE Cohance Lifesciences Ltd	Healthcare	556	down-7.9%	up+1.3%	66	down-52.2%	1.94	Beat +29.3% est. 1.50
ANTHEM Anthem Biosciences Ltd	Healthcare	550	up+4.8%	up+1.9%	173	up+6.8%	3.09	No estimate
SAILIFE Sai Life Sciences Ltd	Healthcare	537	up+35.6%	up+8.3%	84	up+100.0%	4.00	No estimate
CAPLIPOINT Caplin Point Laboratories Ltd	Healthcare	534	up+10.6%	up+4.7%	160	up+22.1%	20.32	No estimate
NEULANDLAB Neuland Laboratories Ltd	Healthcare	514	up+65.3%	up+75.4%	97	up+193.9%	75.49	Beat +37.5% est. 54.92
— Brabourne Enterprises Ltd(merged)	Healthcare	489	up+89.5%	down-3.6%	64	n/a	2.25	No estimate
INDOCO Indoco Remedies Ltd	Healthcare	485	up+12.0%	up+10.2%	-9	n/a	-0.86	Miss -11.1% est. -0.90
SANOFI Sanofi India Ltd	Healthcare	475	down-9.4%	up+17.0%	76	down-7.3%	33.04	Miss -14.1% est. 38.40
FDC FDC Ltd	Healthcare	473	down-8.0%	down-27.0%	28	down-61.1%	1.74	No estimate
POLYMED Poly Medicure Ltd	Healthcare	444	up+5.7%	up+10.2%	92	up+5.7%	9.06	No estimate
AARTIPHARM Aarti Pharmalabs Ltd	Healthcare	418	down-8.7%	up+8.3%	28	down-49.1%	3.08	No estimate
MOREPENLAB Morepen Laboratories Ltd	Healthcare	412	down-5.9%	down-3.1%	41	up+17.1%	0.75	No estimate
RUBICON Rubicon Research Ltd	Healthcare	412	up+39.2%	up+17.0%	54	up+58.8%	3.49	No estimate
REMUS Remus Pharmaceuticals Ltd	Healthcare	400	up+46.5%	n/a	22	up+15.8%	14.85	No estimate
INNOVACAP Innova Captab Ltd	Healthcare	380	up+19.5%	up+8.0%	30	down-14.3%	5.18	No estimate
ONESOURCE OneSource Specialty Pharma Ltd	Healthcare	376	up+12.6%	up+15.0%	10	n/a	0.92	No estimate
SHILPAMED Shilpa Medicare Ltd	Healthcare	370	up+7.6%	up+15.3%	44	up+144.4%	2.25	No estimate
CORONA Corona Remedies Ltd	Healthcare	361	up+15.0%	up+4.0%	52	up+20.9%	8.53	No estimate
PGHL Procter & Gamble Health Ltd	Healthcare	325	up+3.8%	down-4.1%	89	up+8.5%	53.34	No estimate
HIKAL Hikal Ltd	Healthcare	319	down-29.7%	down-16.3%	-35	down-290.7%	-2.83	No estimate
SOLARA Solara Active Pharma Sciences Ltd	Healthcare	314	down-9.5%	down-1.6%	-10	down-225.0%	-2.79	No estimate
ACUTAAS Acutaas Chemicals Ltd	Healthcare	306	up+23.9%	up+47.8%	72	up+89.5%	8.82	No estimate
SHALBY Shalby Ltd	Healthcare	285	up+6.3%	down-3.7%	7	up+250.0%	0.78	No estimate
YATHARTH Yatharth Hospital & Trauma Care Services Ltd	Healthcare	279	up+28.0%	up+8.1%	41	up+32.3%	4.28	No estimate
CONCORDBIO Concord Biotech Ltd	Healthcare	247	down-20.3%	up+21.1%	63	down-36.4%	6.01	No estimate
BLISSGVS Bliss GVS Pharma Ltd	Healthcare	244	up+11.9%	up+17.9%	29	up+11.5%	2.58	No estimate
SMSPHARMA SMS Pharmaceuticals Ltd	Healthcare	242	up+22.8%	up+23.5%	25	up+78.6%	2.70	No estimate
SANOFICONR Sanofi Consumer Healthcare India Ltd	Healthcare	234	up+46.3%	up+5.9%	63	up+40.0%	27.31	No estimate
GUFICBIO Gufic BioSciences Ltd	Healthcare	230	up+12.7%	up+1.3%	15	down-31.8%	1.49	No estimate
WINDLAS Windlas Biotech Ltd	Healthcare	222	up+18.7%	up+5.7%	18	up+12.5%	8.45	No estimate
THYROCARE Thyrocare Technologies Ltd	Healthcare	202	up+14.3%	up+4.8%	43	up+65.5%	3.02	No estimate
VIJAYA Vijaya Diagnostic Centre Ltd	Healthcare	202	up+10.4%	up+7.4%	43	up+2.4%	4.21	No estimate
SUPRIYA Supriya Lifescience Ltd	Healthcare	200	up+20.5%	up+37.9%	50	up+8.7%	6.27	No estimate
ORCHPHARMA Orchid Pharma Ltd	Healthcare	194	down-13.1%	down-26.5%	-6	down-121.0%	-1.13	No estimate
VENUSREM Venus Remedies Ltd	Healthcare	193	up+13.5%	up+40.9%	20	up+400.0%	15.06	No estimate
JSLL Jeena Sikho Lifecare Ltd	Healthcare	190	up+66.5%	up+9.1%	59	up+117.7%	4.73	No estimate
ANUHPHR Anuh Pharma Ltd	Healthcare	186	up+12.0%	0.0%	8	down-46.7%	0.76	No estimate
ADVENZYMES Advanced Enzyme Technologies Ltd	Healthcare	185	up+26.7%	down-0.5%	45	up+36.4%	3.87	No estimate
RPGLIFE RPG Life Sciences Ltd	Healthcare	182	up+5.8%	up+7.7%	37	up+825.0%	22.28	No estimate
BI Bilcare Ltd	Healthcare	178	down-11.9%	down-4.3%	-23	n/a	-5.25	No estimate
— Emergy Phaarma Ltd	Healthcare	171	up+2.0%	up+48.7%	21	down-18.6%	20.14	No estimate
BLUEJET Blue Jet Healthcare Ltd	Healthcare	165	down-20.7%	down-53.5%	52	down-10.3%	3.01	No estimate
LINCOLN Lincoln Pharmaceuticals Ltd	Healthcare	163	up+1.2%	up+5.8%	20	down-23.1%	9.98	No estimate
SUDEEPPHRM Sudeep Pharma Ltd	Healthcare	163	up+9.4%	up+30.4%	47	down-4.1%	4.71	No estimate
SENORES Senores Pharmaceuticals Ltd	Healthcare	162	up+60.4%	up+17.4%	30	up+130.8%	7.03	No estimate
WANBURY Wanbury Ltd	Healthcare	160	down-0.7%	down-1.9%	15	up+89.3%	4.35	No estimate
INDSWFTLAB Ind-Swift Laboratories Ltd	Healthcare	153	up+1,175.0%	0.0%	8	n/a	0.98	No estimate
BAJAJHCARE Bajaj Healthcare Ltd	Healthcare	148	up+11.3%	down-0.7%	11	up+22.2%	3.52	No estimate
OSELDEVICE OSEL Devices Ltd	Healthcare	147	up+69.0%	n/a	15	up+87.5%	8.58	No estimate
FREDUN Fredun Pharmaceuticals Ltd	Healthcare	145	up+35.5%	up+20.8%	10	up+150.0%	6.85	No estimate
PANACEABIO Panacea Biotec Ltd	Healthcare	141	down-4.2%	down-15.3%	-14	down-397.5%	-2.27	No estimate
— Oriental Remedies & Herbals Ltd	Healthcare	138	up+64.3%	n/a	24	up+380.0%	13.78	No estimate
FERMENTA Fermenta Biotech Ltd	Healthcare	130	up+37.0%	down-4.4%	18	up+62.1%	6.14	No estimate
ZOTA Zota Health Care Ltd	Healthcare	129	up+92.5%	up+24.0%	-16	n/a	-5.20	No estimate
FABTECH Fabtech Technologies Ltd	Healthcare	121	up+106.8%	up+78.6%	28	up+449.0%	8.68	No estimate
SYNCOMF Syncom Formulations (India) Ltd	Healthcare	121	up+19.8%	up+3.4%	17	up+54.5%	0.18	No estimate
KOPRAN Kopran Ltd	Healthcare	118	down-22.2%	down-12.8%	-10	down-234.4%	-2.06	No estimate
AMRUTANJAN Amrutanjan Health Care Ltd	Healthcare	118	up+7.1%	up+25.1%	14	up+18.3%	4.83	No estimate
NGLFINE NGL Fine Chem Ltd	Healthcare	117	up+28.6%	up+15.8%	8	down-20.0%	12.79	No estimate
KPL Kwality Pharmaceuticals Ltd	Healthcare	111	up+23.3%	0.0%	14	up+75.0%	13.61	No estimate

About Q2 FY26 earnings data

When are Q2 FY26 results announced?

Q2 FY26 covers the Jul–Sep 2025 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.

Why do some Q2 FY26 growth figures show "n/a" instead of a percentage?

Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.

Does the beat/miss verdict cover every company?

No, and the denominator matters. An analyst consensus existed for 316 of the 6,036 companies that reported Q2 FY26 — 5.2%. Beat, missed and in-line describe only those. Every other company is marked "no estimate" rather than being counted as in line, because nobody forecast it. Revenue and profit growth, by contrast, cover every company in the table.

What counts as an in-line result rather than a beat or a miss?

Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.

Are the figures consolidated or standalone?

Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.

What does the 8-quarter trend line show?

Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.

How do I find only the companies that beat estimates in Q2 FY26?

Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.